Watson challenges Exelon patent; wins Seasonique appeal; launches generic Kadian - Pharmaceutical and Biotechnology News - Pharma Letter

There was an active day for US generics drugmaker Watson Pharmaceuticals (NYSE: WPI), first, confirming that its subsidiary, Watson Laboratories, had filed an Abbreviated New Drug Application with the US Food and Drug Administration seeking approval...